Iterum Therapeutics plc Ordinary Share Share Price Today, Forecast Target, Chat & Where To Buy [ITRM]

Home > Share Prices > Iterum Therapeutics plc Ordinary Share share price (ITRM)

Today's Iterum Therapeutics plc Ordinary Share share price is 0.65 (as of 12:58 31-Oct-2025) which is a change of 0.01 or 0.83% from the last closing price of 0.65 with 216,506 shares traded giving Iterum Therapeutics plc Ordinary Share a market capitalisation of 31,362,681. The most recent daily high has been 0.66 and daily low 0.64. The Iterum Therapeutics plc Ordinary Share share price 52 week high has been 3.02 and the 52 week low 0.61. Based on the most recent Iterum Therapeutics plc Ordinary Share share price opening of 0.65, the current Iterum Therapeutics plc Ordinary Share EPS (earnings per share) are 0.86 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying Iterum Therapeutics plc Ordinary Share Shares

It currently costs 0.65 to buy one share in Iterum Therapeutics plc Ordinary Share (as of 12:58 31-Oct-2025) which is a change of 0.01 or 0.83% from the last closing price of 0.65. To buy shares in Iterum Therapeutics plc Ordinary Share you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Iterum Therapeutics plc Ordinary Share A Good Investment?

The below Iterum Therapeutics plc Ordinary Share share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top